RecruitingNot ApplicableNCT07560631

SeeMe: Using Automated Facial Tracking to Detect Voluntary Behavior in Brain Injury

SeeMe: A Multimodal Behavioral-Electrophysiological Tool for Real-Time Detection of Motor Behavior in Brain Injury Patients


Sponsor

Stony Brook University

Enrollment

80 participants

Start Date

Mar 30, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Objective: This prospective interventional study introduces "SeeMe," an automated, high-resolution computer vision platform designed to objectively quantify microscopic, auditory command-evoked movements in patients with Traumatic Brain Injury (TBI). Current clinical assessments, such as the Glasgow Coma Scale (GCS) and Coma Recovery Scale-Revised (CRS-R), rely on subjective human observation and often fail to detect low-amplitude motor responses, potentially misclassifying up to 25% of patients as unresponsive. Methodology: SeeMe utilizes vector analysis, cross-correlation, and deep neural networks (DNNs) to track individual facial pores and hand movements with sub-millimeter precision (0.5 mm) and high temporal resolution (0.03s). The study will enroll a cohort of 60-80 TBI patients, alongside healthy controls and pharmacologically paralyzed subjects, to validate SeeMe's sensitivity and specificity. Primary Goals: 1. Validation: Compare SeeMe's detection of voluntary motor recovery against gold-standard clinical examinations (CRS-R). 2. Synchronization: Simultaneously record and time-lock electroencephalography (EEG) and electrocorticography (ECoG) with SeeMe-detected movements. 3. Biomarker Identification: Characterize neural signatures (specifically Beta-band oscillations) associated with the return of voluntary behavior. Impact: By providing a real-time, objective measure of motor intention and execution, SeeMe aims to identify "Cognitive-Motor Dissociation" (CMD) earlier than current methods, facilitating more accurate prognostications and laying the framework for future closed-loop neuromodulation (e.g., Vagus Nerve Stimulation) to accelerate TBI recovery.


Eligibility

Min Age: 22 YearsMax Age: 85 Years

Inclusion Criteria16

  • Group 1: Traumatic Brain Injury (TBI) Cohort
  • Adults (22+) with a history of acute traumatic brain injury
  • Documented loss of consciousness with a Glasgow Coma Scale (GCS) score less than or equal to 8 upon hospitalization
  • Clinically stable as determined by the primary neurosurgery or ICU team
  • Intact auditory pathways as confirmed by BAERs
  • Family consent for study participation
  • Adults 22+ with no history of neurological or psychiatric disorders
  • Normal baseline neurological examination
  • Intact auditory pathways
  • Ability to provide informed consent
  • Ability to follow simple auditory commands in English
  • Adults (22+) undergoing elective spine surgery
  • Requirement of general anesthesia and pharmacological paralysis (neuromuscular blockade) as part of the standard surgical procedure
  • Clinically stable for study procedures as determined by the anesthesia and surgical teams.
  • Intact auditory pathways
  • Ability to provide informed pre-operative consent

Exclusion Criteria20

  • Hearing Impairment confirmed via absence of Brainstem Auditory Evoked Responses (BAERs) that would prevent the patient from hearing the auditory commands
  • No legal authorized representative (LAR) available to provide informed consent for the patients in a comatose state
  • Any other medical condition that, in the judgment of the investigator, makes participation in the study unsafe.
  • Pregnant women
  • Any previous history of traumatic brain injury
  • Any neurodegenerative disease such as dementia
  • Group 2: Healthy Control Cohort
  • Hearing Impairment that would prevent the participant from hearing the auditory commands
  • Any previous history of severe traumatic brain injury (TBI)
  • Any neurodegenerative disease (e.g., dementia)
  • Any motor impairment (e.g., facial palsy, carpal tunnel syndrome) that would interfere with facial or hand movement tracking
  • Any other medical condition that, in the judgment of the investigator, makes participation in the study unsafe
  • Pregnant women
  • Group 3: Sedated/Anesthetized Cohort
  • Hearing Impairment that would prevent the patient from hearing the auditory commands
  • Any previous history of severe traumatic brain injury
  • Any neurodegenerative disease such as dementia
  • Significant baseline facial or hand motor deficits prior to the administration of anesthesia
  • Any other medical condition that, in the judgment of the investigator, makes participation in the study unsafe
  • Pregnant women

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTSeeMe Multimodal Auditory Command Protocol

A standardized, computer-controlled auditory stimulation (AS) protocol designed to elicit and quantify microscopic motor responses. Protocol Details: Stimuli: Participants are presented with five distinct auditory commands: 1) 'Stick out your tongue,' 2) 'Open your eyes,' 3) 'Show me a smile,' 4) 'Close your hands,' and 5) a neutral control command ('Today is a sunny day'). Timing: Each command is presented 10 times via single-use headphones with a randomized 30-45 second jittered interval between trials to distinguish stimulus-evoked responses from spontaneous arousal. Data Capture: Responses are captured using high-resolution video (Panasonic HC-2000X) at 0.03s temporal resolution and synchronized millisecond-level EEG/ECoG. Analysis: Displacement heatmaps are generated via facial pore vector analysis and classified using a bidirectional long short-term memory (LSTM) neural network to determine the statistical significance of motor initiation compared to a 15-minute resting base


Locations(1)

Stony Brook University Hospital

Stony Brook, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07560631


Related Trials